United Therapeutics (UTHR) Current Assets (2009 - 2026)
United Therapeutics (UTHR) reported Current Assets of $3.48 billion for Q2 2026, down 9.0% from $3.83 billion a year earlier but up 21.3% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, United Therapeutics posted Current Assets of $3.7 billion, down 4.4% from FY2024.
- Current Assets has a five-year compound annual growth rate of 11.3% (FY2020 to FY2025).
- By year, Current Assets came in at $3.87 billion in FY2024 (+9.1%), $3.55 billion in FY2023 (+5.0%), $3.38 billion in FY2022 (+45.5%) and $2.32 billion in FY2021 (+7.2%).
- Five-year quarterly Current Assets spans a low of $2.32 billion in Q4 2021 and a high of $4 billion in Q3 2024.
- Year over year, Current Assets has now declined in each of the last four quarters, with an average decline of 0.2% over the last eight quarters.
- The high point for year-over-year Current Assets in five years was Q4 2022 (growth of 45.5%); the low point was Q1 2026 (a decline of 27.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.87 billion (Q1 2026), $3.7 billion (Q4 2025) and $3.49 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 45.01 Bn |
| 10 | United Therapeutics | 25.03 Bn | 15.22 Bn | 733.40 Mn | 2.88 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.88 Bn |
| Jun 30, 2026 | 3.48 Bn |
| Mar 31, 2026 | 2.87 Bn |
| Dec 31, 2025 | 3.70 Bn |
| Sep 30, 2025 | 3.49 Bn |
| Jun 30, 2025 | 3.83 Bn |
| Mar 31, 2025 | 3.94 Bn |
| Dec 31, 2024 | 3.87 Bn |
| Sep 30, 2024 | 4.00 Bn |
| Jun 30, 2024 | 3.62 Bn |
| Mar 31, 2024 | 3.25 Bn |
| Dec 31, 2023 | 3.55 Bn |
| Sep 30, 2023 | 3.46 Bn |
| Jun 30, 2023 | 3.21 Bn |
| Mar 31, 2023 | 3.19 Bn |
| Dec 31, 2022 | 3.38 Bn |
| Sep 30, 2022 | 3.06 Bn |
| Jun 30, 2022 | 2.68 Bn |
| Mar 31, 2022 | 2.59 Bn |
| Dec 31, 2021 | 2.32 Bn |
API Access
United Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();